Avata Biosciences Signs Co-Development and Licensing Agreement with Oceanus Bio for Exclusive Rights in Japan and Asia (Excluding China and India) for Novel Adult and Pediatric Oral Cannabidiol Therapies for Development in Epilepsy and Schizophrenia
LONDON & MELBOURNE, Australia & PHOENIX--(BUSINESS WIRE)--Avata Biosciences Holdings Ltd (‘Avata’), a pioneering biopharmaceutical company specializing in neuroscience drug discovery and clinical d...
3 months ago